Acevedo GS, Espino SS, Gallardo GJM, Velásquez TB, Camargo ML, Guzmán HME

Language: Spanish
References: 26
Page: 230-245
PDF size: 429.82 Kb.

ABSTRACT

The human placenta, even a puzzle in a lot of aspects, has been motive of exhaustive study in last decades, although; even escape to our comprehension to many aspects of immunology and genetics of this complex organ, we can, with the actual knowledge, make a practical and total concept of the most important aspects that let us understand and associate in its exact latitude the pathologies that affect the fetal grown and his interaction with the environment.

REFERENCES

1. Moffett A, Loke YW. The immunological paradox of pregnancy: A reappraisal. Placenta 2004; 25: 1-8.

2. Sherer DM, Abulafia O. Angiogénesis during implantation, and placental and early embryonic development. Placenta 2001; 22: 1-13.

3. Demir R, Kayisli UA, Seval Y, Celic-Ozeci C, et al. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta 2004; 25: 560-72.

4. Arroyo J, Torry RJ, Torry DS. Deferential regulation of placenta growth factor (PlGF) –mediated signal transduction in human primary term trophoblast and endothelial cells. Placenta 2004; 25: 379-86.

5. Reganault TRH, Orbus RJ, de Vrijer B, Davidsen ML, et al. Placental expression of VEGF and their receptors in a model of placental insuffiency – intrauterine growth restriction (Pl-IUGR). Placenta 2002; 23: 132-44.

6. Kaufmann P, Scheffen I. Placental development. En: Polin RA, Fox WW (eds.). Fetal and neonatal physiology. Philadelphia: WB Saunders Company; 1998, p. 59-115.

7. Kelly B, Stone S, Poston L. Cardiovascular adaptation to pregnancy: The role of altered vascular structure. Fet Mat Med Rev 1999; 11: 105-16.

8. Hauguel de Mouzon S, Shafrir E. Carbohidrate and fat metabolism and related hormonal regulation in normal and diabetic placenta. Placenta 2001; 22: 619-27.

9. Haggarty P. Placental regulation of fatty acid delivery and its effect on fetal growth-A review. Placenta 2002; 23: S28-S38.

10. Battaglia FC, Regnault RH. Placental transport and metabolism of amino acids. Placenta 2001; 22: 146-61.

11. Cariappa R, Heath-Monnig E, Smith CH. Isoforms of amino acid transporters in placental syncytiotrophoblast: plasma membrane localization and potential role in maternal/fetal transport. Placenta 2004; 24: 713-26.

12. Jannson T, Ylben K, Wennergren M, Powell TL. Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction. Placenta 2002; 23: 392-9.

13. Manning FA. Fetal Medicine. Pinciples and practice. 1st. Ed. Ed. Masson; 1995.

14. Kalousek DK, Vekemans M. Confined placental mosaicism. J Med Genet 1996; 33: 529-33.

15. Lin CC, Santolaya-Forjas J. Current concepts of fetal growth restriction: Part I. Causes, classification, and pathophysiology. Obstet Gynecol 1998; 92: 1044-55.

16. Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004; 25: 103-13.

17. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during pregnancy. Placenta 2004; 25: 114-26.

18. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004; 25: 127-39.

19. Villanueva LA, Pedernera E, García Lara E. Bases fisiopatológicas de la preeclampsia: una hipótesis. Ginecol Obstet Méx 1999; 67: 246-52.

20. Goldman-Wohl D, Greenfield C, Haimov-Kochman R, Ariel I, et al. Eph and Ephrin expression in normal placental development and preeclampsia. Placenta 2004; 25: 623-30.

21. Thapa L, He CM, Chen HP. Study on the expression of angiotensin II receptor subtype 1 in the placenta of pregnancy-induced hypertension. Placenta 2004; 25: 637-41.

22. Huppertz B. Kaufmann P, Kingdom J. Trophoblast turnover in health and disease. Fet Mat Med Rev 2002; 13: 103-8.

23. Rajakumar A, Brandon HM, Daftary A, Ness R, Conrad KP. Evidence for the functional activity of hypoxia inducible transcription factors overexpressed in preeclamptic placentae. Placenta 2004; 25: 763-9.

24. Fowden AL. The insulin-like growth factor and feto-placental growth. Placenta 2003; 24: 803-12.

25. Hauguel de Mouzon S, Shafrir E. Carbohydrate and fat mebolism and related hormonal regulation in normal and diabetic placenta. Placenta 2001; 22: 619-27.

26. Couglan MT, Vervaart PP, Parmezel M, Georgiou HM, Rice GE. Altered placental oxidative stress status in fetational diabetes mellitus. Placenta 2004; 25: 78-94.